Cardiac Transplantation First Year Experience

pp 555-559

Authors

  • G. Bortman Para optar a Miembro Titular de la Sociedad Argentina de Cardiología
  • M. Sellanes
  • M. Russo
  • N. Russo
  • M. Campos
  • C. Cardenas
  • C. Nojek Miembro Titular SAC

DOI:

https://doi.org/10.7775/rac.v63i6.3779

Keywords:

Cardiac transplantation, Cyclosporine, Immunosuppression

Abstract

Background

The excellent results all over the world, put on the way of our intratoracic transplantation program.

Methods

We incorporate patients with severe heart failure, without any probability of other therapeutic approach. Using an immunosuppression protocol with triple drug, without cyclosporine in the perioperative time.

Results

The 90,5% survival in the perioperative time, with none other mortality in the follow up (13 month). We had similar incidence of rejection, and infection than the literature. We made long distance harvesty, considerated in previous time us a high risk. We present a low incidence of renal disfunction in the perioperative time.

Conclusion

This data is satisfactory for the first year of this transplant program. The scheme of triple drug without induction therapy, and a late begin of cyclosporine shows similar results than general literature, with low incidence of renal complication.

Downloads

Published

2026-04-09

Issue

Section

ORIGINAL ARTICLES